ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

7,75
0,00
(0,00%)
Fermé 09 Février 10:00PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
7,75
Prix Achat
7,80
Prix Vente
7,85
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
7,75
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
24 458 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-372,41
Bénéfice par action (BPA)
-0,01
Chiffre d'affairess
113,05M
Bénéfice net
-214k

À propos de Medexus Pharmaceuticals Inc

Secteur
Pharmaceutical Preparations
Industrie
Blank Checks
Site Web
Siège social
Bolton, Gbr
Fondé
2013
Medexus Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la TSX Venture Exchange avec le ticker MDP. Le dernier cours de clôture d'Medexus Pharmaceuticals était de $7,75. Au cours de la dernière année, les actions de Medexus Pharmaceuticals ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Medexus Pharmaceuticals compte actuellement 24 458 000 actions en circulation. La capitalisation boursière d'Medexus Pharmaceuticals est de $189,55 million. Medexus Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -372.41.

MDP Dernières nouvelles

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced...

Medexus Appoints New Chief Financial Officer

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in C...

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered...

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and available liquidity of $24.8 million at March 31, 2021...

Medexus Announces Graduation to the Toronto Stock Exchange

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

Medexus to Present at Raymond James Human Health Innovation Conference

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

Medexus Schedules Fiscal Year 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today...

Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it...

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MDP - Frequently Asked Questions (FAQ)

What is the current Medexus Pharmaceuticals share price?
The current share price of Medexus Pharmaceuticals is $ 7,75
How many Medexus Pharmaceuticals shares are in issue?
Medexus Pharmaceuticals has 24 458 000 shares in issue
What is the market cap of Medexus Pharmaceuticals?
The market capitalisation of Medexus Pharmaceuticals is CAD 189,55M
What is the 1 year trading range for Medexus Pharmaceuticals share price?
Medexus Pharmaceuticals has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Medexus Pharmaceuticals?
The price to earnings ratio of Medexus Pharmaceuticals is -372,41
What is the cash to sales ratio of Medexus Pharmaceuticals?
The cash to sales ratio of Medexus Pharmaceuticals is 0,7
What is the reporting currency for Medexus Pharmaceuticals?
Medexus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Medexus Pharmaceuticals?
The latest annual turnover of Medexus Pharmaceuticals is USD 113,05M
What is the latest annual profit for Medexus Pharmaceuticals?
The latest annual profit of Medexus Pharmaceuticals is USD -214k
What is the registered address of Medexus Pharmaceuticals?
The registered address for Medexus Pharmaceuticals is 35 NIXON ROAD, UNIT 1, BOLTON, L7E 1K1
What is the Medexus Pharmaceuticals website address?
The website address for Medexus Pharmaceuticals is www.medexus.com
Which industry sector does Medexus Pharmaceuticals operate in?
Medexus Pharmaceuticals operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ADG.HArcus Development Group Inc
$ 0,025
(400,00%)
260,5k
CEN.HClaren Energy Corp
$ 0,155
(342,86%)
25k
SGUSignature Resources Ltd
$ 0,06
(100,00%)
1,2M
BOCABocana Resources Corp
$ 0,01
(100,00%)
64k
CPICarlton Precious Inc
$ 0,09
(80,00%)
34,5k
RGIReco International Group Inc
$ 0,01
(-50,00%)
28k
CNST.PConstellation Capital Corp
$ 0,04
(-42,86%)
20k
GAR.HGreen Arrow Resources Inc
$ 0,025
(-37,50%)
2k
CBLUClear Blue Technologies International Inc
$ 0,02
(-33,33%)
11k
MTLOMartello Technologies Group Inc
$ 0,01
(-33,33%)
4,74k
LUCALuca Mining Corp
$ 1,02
(5,15%)
7,95M
OMIOrosur Mining Inc
$ 0,245
(44,12%)
2,57M
AGAGArgenta Silver Corp
$ 0,26
(6,12%)
2,32M
SXLSlam Exploration Ltd
$ 0,025
(25,00%)
1,88M
CHSComprehensive Healthcare Systems Inc
$ 0,01
(0,00%)
1,87M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock